Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Ltd has announced the quotation of 2,404,728 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from October 9, 2025. This move is part of the company’s strategic efforts to enhance its market presence and provide liquidity to its stakeholders, potentially strengthening its position in the medical technology sector.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative respiratory imaging solutions. The company is known for its advanced lung imaging technology, which aims to enhance diagnostic capabilities and improve patient outcomes in respiratory care.
Average Trading Volume: 7,499,504
Technical Sentiment Signal: Buy
Current Market Cap: A$1.14B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.